Perspective Therapeutics Inc. (NYSE AMERICAN: CATX) Stock Information | RedChip

Perspective Therapeutics Inc. (NYSE AMERICAN: CATX)


$12.63
+0.2850 ( +2.31% ) 705.2K

Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.

Market Data


Open


$12.63

Previous close


$12.34

Volume


705.2K

Market cap


$849.42M

Day range


$11.94 - $12.80

52 week range


$2.05 - $19.05

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 21 Jan 22, 2024
8-k 8K-related 13 Jan 17, 2024
8-k/a 8K-related 16 Jan 17, 2024
8-k 8K-related 15 Jan 17, 2024
8-k 8K-related 100 Jan 17, 2024
8-k 8K-related 15 Jan 11, 2024
8-k 8K-related 15 Jan 05, 2024
8-k 8K-related 89 Jan 03, 2024
4 Insider transactions 1 Dec 26, 2023
4 Insider transactions 1 Dec 19, 2023

Latest News